Shares of Becton Dickinson & Co. BDX slipped 1.11% to $224.92 Tuesday, on what proved to be an all-around grim trading ...

The stock's rise snapped a four-day losing streak.

Proficio Capital Partners LLC bought a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during ...

Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report)’s stock price fell 0.3% during trading on Thursday following insider selling activity. The company traded as low as $222.01 and last traded ...

Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...

Learn more about whether Becton, Dickinson and Company or GE HealthCare Technologies Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

A new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...

On Tuesday, 11 March 2025, Becton Dickinson (NYSE: BDX) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic focus on separating its Life Sciences business ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.